April 16th 2025
The drug is approved for the short-term treatment of acute repetitive seizures, also known as seizure clusters, which differ from a patient’s normal seizure pattern.
PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices
April 30, 2025 | 11:15 AM ET
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Stress Ulcer Prophylaxis May Not Prevent Gastrointestinal Bleeding in Neonates
December 4th 2023According to a poster presented at ASHP Midyear 2023, stress ulcer prophylaxis (SUP) did not increase adverse effects, suggesting limited preventive benefits for gastrointestinal bleeding (GIB) in neonates.
Navigating a Complicated Pediatric COVID-19 Case With Immunomodulatory Therapies
November 6th 2023A poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition, featured a complex pediatric case involving SARS-CoV-2, bacterial coinfection, multiorgan failure, thrombotic microangiopathy, and systemic hyperinflammation.
Review of FDA Approvals for Pediatric Obesity Management
GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Multiple Lisdexamfetamine Dimesylate Generics for ADHD in Children Approved by FDA
September 13th 2023In addition to approving these generics for children, adolescents and adults with ADHD, the generic chewable tablets and capsules are also approved for adults with moderate to severe binge-eating disorder.